91 related articles for article (PubMed ID: 10853417)
1. [Epidermal growth factor receptors and their ligands in endometrial carcinoma: correlation with clinico-morphologic factors and steroid receptors].
Gershtein ES; Bocharova LB; Ermilova VD; Laktionov KP; Kushlinskiĭ
Vopr Onkol; 2000; 46(2):180-6. PubMed ID: 10853417
[TBL] [Abstract][Full Text] [Related]
2. Expression of epidermal growth factor family proteins and epidermal growth factor receptor in human endometrium.
Niikura H; Sasano H; Kaga K; Sato S; Yajima A
Hum Pathol; 1996 Mar; 27(3):282-9. PubMed ID: 8600044
[TBL] [Abstract][Full Text] [Related]
3. The expression analysis of the estrogen and progesterone receptors in endometrial carcinomas.
Olech-Fudali E; Chibowski D; Skomra D; Walczyna B
Ann Univ Mariae Curie Sklodowska Med; 2001; 56():319-25. PubMed ID: 11977333
[TBL] [Abstract][Full Text] [Related]
4. FGFR2 alterations in endometrial carcinoma.
Gatius S; Velasco A; Azueta A; Santacana M; Pallares J; Valls J; Dolcet X; Prat J; Matias-Guiu X
Mod Pathol; 2011 Nov; 24(11):1500-10. PubMed ID: 21725289
[TBL] [Abstract][Full Text] [Related]
5. Expression of pS2 protein in endometrial carcinomas: correlation with clinicopathologic features and sex steroid receptor status.
Koshiyama M; Yoshida M; Konishi M; Takemura M; Yura Y; Matsushita K; Hayashi M; Tauchi K
Int J Cancer; 1997 Jun; 74(3):237-44. PubMed ID: 9221798
[TBL] [Abstract][Full Text] [Related]
6. Epidermal growth factor receptor immunostaining and epidermal growth factor receptor-tyrosine kinase activity in proliferative and neoplastic human endometrium.
Miturski R; Semczuk A; Postawski K; Jakowicki JA
Tumour Biol; 2000; 21(6):358-66. PubMed ID: 11006576
[TBL] [Abstract][Full Text] [Related]
7. Expression of c-erbB-2 protein and epidermal growth receptor in endometrial carcinomas. Correlation with clinicopathologic and sex steroid receptor status.
Wang D; Konishi I; Koshiyama M; Mandai M; Nanbu Y; Ishikawa Y; Mori T; Fujii S
Cancer; 1993 Nov; 72(9):2628-37. PubMed ID: 8104681
[TBL] [Abstract][Full Text] [Related]
8. [The prognostic factors in endometrial carcinoma (EC)].
Gorchev G
Akush Ginekol (Sofiia); 1995; 34(2):51-3. PubMed ID: 8651426
[No Abstract] [Full Text] [Related]
9. Immunohistochemical expression of PTEN in normal, hyperplastic and malignant endometrium and its correlation with hormone receptors, bcl-2, bax, and apoptotic index.
Kapucuoglu N; Aktepe F; Kaya H; Bircan S; Karahan N; Ciriş M
Pathol Res Pract; 2007; 203(3):153-62. PubMed ID: 17317031
[TBL] [Abstract][Full Text] [Related]
10. Clinical, histopathologic, and immunohistochemical features of microglandular adenosis and transition into in situ and invasive carcinoma.
Khalifeh IM; Albarracin C; Diaz LK; Symmans FW; Edgerton ME; Hwang RF; Sneige N
Am J Surg Pathol; 2008 Apr; 32(4):544-52. PubMed ID: 18300793
[TBL] [Abstract][Full Text] [Related]
11. Effects of tamoxifen on steroid hormone receptors and hormone concentration and the results of DNA analysis by flow cytometry in endometrial carcinoma.
Nola M; Jukić S; Ilić-Forko J; Babić D; Uzarević B; Petrovecki M; Suchanek E; Skrablin S; Dotlić S; Marusić M
Gynecol Oncol; 1999 Mar; 72(3):331-6. PubMed ID: 10053103
[TBL] [Abstract][Full Text] [Related]
12. Expression of ras p21 oncoprotein in normal and neoplastic human endometrium.
Scambia G; Catozzi L; Benedetti-Panici P; Ferrandina G; Battaglia F; Giovannini G; Distefano M; Pellizzola D; Piffanelli A; Mancuso S
Gynecol Oncol; 1993 Sep; 50(3):339-46. PubMed ID: 8406198
[TBL] [Abstract][Full Text] [Related]
13. 5-year survival rate in endometrial carcinoma stage I-II related to steroid receptor concentration, degree of differentiation, age and myometrial invasion.
Lindahl B; Fernö M; Gullberg B; Norgren A; Willén R
Anticancer Res; 1992; 12(2):409-12. PubMed ID: 1580559
[TBL] [Abstract][Full Text] [Related]
14. Significance of epidermal growth factor receptor expression in primary human endometrial cancer.
Scambia G; Benedetti Panici P; Ferrandina G; Battaglia F; Distefano M; D'Andrea G; De Vincenzo R; Maneschi F; Ranelletti FO; Mancuso S
Int J Cancer; 1994 Jan; 56(1):26-30. PubMed ID: 8262674
[TBL] [Abstract][Full Text] [Related]
15. Proliferative activity in postmenopausal endometrium: the lurking potential for giving rise to an endometrial adenocarcinoma.
Sivridis E; Giatromanolaki A
J Clin Pathol; 2004 Aug; 57(8):840-4. PubMed ID: 15280405
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical study of HER-2/neu, epidermal growth factor receptor, and steroid receptor expression in normal and malignant endometrium.
Bigsby RM; Li AX; Bomalaski J; Stehman FB; Look KY; Sutton GP
Obstet Gynecol; 1992 Jan; 79(1):95-100. PubMed ID: 1345772
[TBL] [Abstract][Full Text] [Related]
17. Plasminogen activator inhibitors in endometrial adenocarcinoma.
Gleeson NC; Gonsalves R; Bonnar J
Cancer; 1993 Sep; 72(5):1670-2. PubMed ID: 8348499
[TBL] [Abstract][Full Text] [Related]
18. Expression of replication-licensing factors MCM2 and MCM3 in normal, hyperplastic, and carcinomatous endometrium: correlation with expression of Ki-67 and estrogen and progesterone receptors.
Kato K; Toki T; Shimizu M; Shiozawa T; Fujii S; Nikaido T; Konishi I
Int J Gynecol Pathol; 2003 Oct; 22(4):334-40. PubMed ID: 14501812
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of p53, bcl-2 and EGFR in carcinoma of the endometrium.
Athanassiadou P; Petrakakou E; Liossi A; Nakopoulou L; Zerva C; Dimopoulos A; Athanassiades P
Acta Cytol; 1999; 43(6):1039-44. PubMed ID: 10578976
[TBL] [Abstract][Full Text] [Related]
20. [Expression of epidermal growth factor receptor and concentrations of epidermal growth factor and melatonin in endometrial carcinoma].
Dznelashvili N; Kasradze D; Tavartkiladze A
Georgian Med News; 2014 Oct; (235):17-24. PubMed ID: 25416211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
